Universe Pharmaceuticals Cash Flow Statement (2020-2024) | UPC

Cash Flow Statement Sep2020 Sep2021 Mar2022 Sep2022 Mar2023 Sep2023 Mar2024 Sep2024
Operating Activities
Asset Writedowns and Impairment 555.11B
Change in Working Capital
Change in Account Payables 0.01B-0.01B0.00B-0.00B0.00B-0.00B
Change in Accured Expenses 0.00B-0.00B0.00B-0.00B0.00B-0.00B
Change in Taxes 0.00B-0.00B0.00B-0.00B0.00B-0.00B
Other Working Capital Changes -0.00B0.00B-0.00B0.00B-0.00B
Investing Activities
Acquisitions 0.00B0.00B0.00B0.00B
Change in Acquisitions & Divestments 0.01B14,344.08B0.01B-0.01B13,219.00B0.00B
Financing Activities
Debt Issuance and Repayment
Non-Current Debt 100,000.00B166,666.67B166,666.67B
Net Debt Issuances and Repayments 100,000.00B166,666.67B166,666.67B
Additional items
Beginning Cash Balance 0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.03B